Staar Surgical market cap STAA
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $1.3B
- Highest close in our data
- $7.4B
- Sep 2021
Staar Surgical is worth $1.3B at the close on Nov 2, 2026, at $24.94 a share.
That is down 5% over the last year and down 77% over five years.
Its highest close in our data was $7.4B in Sep 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.3B | $800.8M | $1.6B | +8% |
| 2025 | $1.2B | $756.4M | $1.4B | −3% |
| 2024 | $1.2B | $1.2B | $2.4B | −22% |
| 2023 | $1.5B | $1.5B | $3.8B | −35% |
| 2022 | $2.3B | $2.3B | $5.4B | −46% |
| 2021 | $4.3B | $3.9B | $7.4B | +19% |
| 2020 | $3.7B | $1.2B | $3.8B | +124% |
| 2019 | $1.6B | $1B | $1.8B | +18% |
| 2018 | $1.4B | $577.8M | $2.1B | +116% |
| 2017 | $638M | $372.5M | $697.7M | +45% |
| 2016 | $440.6M | $214.6M | $462.9M | +55% |
| 2015 | $284.8M | $231.9M | $412.9M | −20% |
| 2014 | $354.8M | $336.3M | $725.9M | −41% |
| 2013 | $600.5M | $192.2M | $600.5M | +182% |
| 2012 | $213M | $185.7M | $410.1M | −44% |
| 2011 | $378.6M | $190.1M | $409.7M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Staar Surgical's size, closest first, today.
| Company | Market cap |
|---|---|
| STAAStaar Surgical | $1.3B |
| CDRECadre | $1.3B |
| EYENational Vision | $1.4B |
| BVSBioventus | $1.1B |
| IARTIntegra Lifesciences | $1.1B |
| IRMDIradimed | $1B |
| LMATLemaitre Vascular | $1.9B |
| INSPInspire Medical Systems | $1.9B |
| UFPTUFP Technologies | $2.2B |
| MOVMovado | $710.9M |
| WRBYWarby Parker | $2.9B |
| Peer median | $1.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Staar Surgical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.